October 17, 2018 — Shimadzu Medical Systems USA and Change Healthcare have entered a partnership through which Shimadzu will offer Change Healthcare Cardiology Hemo, along with its Trinias line of angiography systems. The announcement was made at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21-25 in San Diego.
More than 130 million adults in the U.S. are projected to have some form of cardiovascular disease (CVD) by 2035. The costs associated with caring for CVD are unsustainable, and reimbursement models are shifting. To support providers looking to grow their cardiovascular service line and implement technology while maintaining financial responsibility, augmenting the Trinias line is part of a complete interventional lab package.
Trinias is a single-plane system available in floor or ceiling mounts or as a Bi-plane mounted system, offering what Shimadzu calls unmatched design movements around the patient. Change Healthcare Hemo is the integrated hemodynamic monitoring system for cardiology departments that need to aggregate hemodynamic data, waveforms and images in one cardiac patient record. The combined offering is now available through Shimadzu and its reseller network.
For more information: www.shimadzu.com/med
January 31, 2024 
